R Swamy Venuturupalli, M.D. practices rheumatology in Beverly Hills, CA. According to Medicare claims data, R Swamy cared for 5,064 Medicare patients across 285,367 services. The services billed most often include injection, tocilizumab, 1 mg, injection, tezepelumab-ekko, 1 mg, and injection, denosumab, 1 mg. The provider's National Provider Identifier (NPI) is 1063437648.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
8750 WILSHIRE BLVD SUITE 350
Beverly Hills, CA 90211
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
285,367 services · 5,064 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
1,406 | More than most peers in Rheumatology |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
1,345 | More than most peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
895 | More than most peers in Rheumatology |
| Injection, tocilizumab, 1 mg | Drug given | J3262 |
112,505 | More than most peers in Rheumatology |
| Injection, tezepelumab-ekko, 1 mg | Drug given | J2356 |
42,210 | Too few peers to compare |
| Injection, denosumab, 1 mg | Drug given | J0897 |
30,060 | More than most peers in Rheumatology |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0717 |
22,400 | Less often than most peers in Rheumatology |
| Injection, romosozumab-aqqg, 1 mg | Drug given | J3111 |
18,270 | As often as other peers in Rheumatology |
| Injection, inclisiran, 1 mg | Drug given | J1306 |
17,608 | More often than most peers in Rheumatology |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
16,900 | More often than most peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
R Swamy Venuturupalli is a rheumatologist in Beverly Hills, CA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
R Swamy Venuturupalli is listed at 8750 Wilshire Blvd Suite 350, Beverly Hills, CA 90211. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (310) 652-0010. Contact the office directly to confirm availability and scheduling.
NPI registry
R Swamy Venuturupalli's National Provider Identifier is 1063437648. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
R Swamy Venuturupalli attended Other, graduating in 1995. This comes from the CMS National Downloadable File.
CMS public data
R Swamy Venuturupalli has 31 years experience. Calculated from a graduation year of 1995, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, R Swamy Venuturupalli performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by R Swamy Venuturupalli. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.